普罗西亚尼丁与罗克萨杜斯塔特在小鼠脏贫血上表现出协同作用
Mingyang Cui1, Zhe Wang2, Jiaxin Shi1
1Department of Nutrition and Health, China Agricultural University, Beijing, China.
Frontiers in pharmacology
|November 28, 2025
概括
将普西亚尼丁与罗克萨杜斯塔特结合,为慢性病 (CKD) 贫血提供了一种新的治疗方法. 这种协同方法可以改善功能和红细胞的产生,同时降低与传统疗法相关的风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 慢性病 (CKD) 经常导致贫血,通常用红色素形成刺激剂 (ESA) 和铁进行治疗,这些药物具有心血管风险.
- 在黑色古吉果和木中发现的普罗基亚尼丁,表现出脏保护作用.
- 罗沙沙斯塔特是一种新兴的贫血治疗方法.
研究的目的:
- 在CKD小鼠模型中,研究普西亚尼丁和罗克萨杜斯塔特对脏贫血的联合治疗效果.
- 评估这种组合对红色素形成,功能,铁代谢和炎症的影响.
主要方法:
- 通过使用腺素建立了CKD的小鼠模型.
- 治疗小鼠的药物是普西亚尼丁,罗克萨杜斯塔特或两者的组合.
- 红色素形成,功能,铁代谢和炎症通过血液学,遗传学和基因表达分析进行了评估.
主要成果:
- 单独使用普罗基亚尼丁可以改善功能和红细胞生成.
- 罗克萨杜沙特增强了红质形成和铁代谢.
- 组合疗法在血液学参数,功能和炎症方面表现出卓越的改善,而普拉基亚尼丁减轻了罗沙沙沙特诱导的血栓形成.
结论:
- 普西亚尼丁和罗克萨杜斯塔特的组合是治疗慢性病脏贫血的有希望的策略.
- 这种方法通过改善功能和减轻不良影响来提高治疗疗效和安全性.
- 需要进一步的研究来优化这种组合用于临床使用.
更多相关视频
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
8.8K
08:21A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
5.5K
相关概念视频
01:11Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K